Oncology and Pathology, MV
1 – 10 of 2011
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Benefits, barriers and opinions on multidisciplinary team meetings : A survey in Swedish cancer care
- Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
- Prognostic and Predictive Markers in Primary Breast Cancer - Quality Assurance and Long-term Effects of Adjuvant tamoxifen Treatment
- Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer : The RASTEN trial
- Immune gene expression and response to chemotherapy in advanced breast cancer
- Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
- The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant : Breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
- Claudin-4 Expression is Associated with Survival in Ovarian Cancer but Not with Chemotherapy Response
- A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort
- Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis